ArticleFrontiers in pharmacology2025
A double-layer PLGA/CoI-MeHA tissue engineering scaffold for urethral reconstruction.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Urethral injury caused by various reasons usually leads to urethral stricture. And severe urethral stricture can further induce complications such as bladder stones, fistulas, sepsis, and even renal failure. At present, surgical methods such as urethral reconstruction and end-to-end anastomosis are commonly used to solve this problem. But this treatment method often has a high recurrence rate. So simply relying on the repair of surrounding autologous tissue cells to reconstruct the urethra is difficult to achieve long-term stability, and constructing a suitable urethral graft is an effective and feasible solution. Methods: Here, we designed and prepared a double-layer PLGA/CoI-MeHA tissue engineering scaffold to better simulate the natural anatomy of the urethra and achieve urethral tissue regeneration and reconstruction in patients with urethral stricture and Hypospadias caused by various reasons. The double-layer tissue engineering scaffold was generated using electrospinning and light curing technology. Results: Through electrospinning and light curing technology, we successfully screened the PLGA/CoI (7:3) electrospun membrane and MeHA (40.72%) hydrogel. Furthermore, we successfully prepared PLGA/CoI-MeHA bilayer urethral stents loaded with rabbit urethral smooth muscle cells and rabbit urethral epithelial cells, respectively, and achieved favorable results for urethral defect repair and urethral reconstruction in rabbits. The mechanical characterization of the scaffold indicates that it has sufficient mechanical strength to meet experimental and clinical needs. In addition, it showed satisfactory biocompatibility in cell experiments and in the in vitro degradation experiments. The double-layer urethral stents demonstrated exceptional performance in repairing urethral defects in rabbits. Discussion: We had successfully designed and prepared a double-layer PLGA/CoI-MeHA tissue engineering scaffold. The stent displayed sufficient mechanical strength, good biocompatibility and degradation characteristics, and effectively simulated the natural anatomy of urethra, achieving satisfactory urethral defect reconstruction results.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.